Related Articles
Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone
miR-20b-5p is a novel biomarker for detecting prostate cancer
Blood‑based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer‑risk stratification
Favorable long‑term oncological and urinary outcomes of incidental prostate cancer following holmium laser enucleation of the prostate
Volatile metabonomic profiling in urine to detect novel biomarkers for B‑cell non‑Hodgkin's lymphoma